Eli Lilly

Eli Lilly

company United States

Eli Lilly and Company is an American pharmaceutical company, founded in 1876, that is known for its contributions to the development of various medications across multiple therapeutic areas, including diabetes, oncology, and immunology. The company has gained recognition for its diabetes treatment, Mounjaro, which is part of the GLP-1 receptor agonist class. Eli Lilly is committed to improving patient outcomes through innovative products and has a strong focus on research and development.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
16,767
Power
17$
Sentiment
6.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Ireland 2 6.00 0.33% +0% 5,030,000 16,767 $5,100 17$
Totals 2 5,030,000 16,767 $5,100 17$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Israel Israel: The article is presented with the support of Eli Lilly without involvement in the content. 5

ידיעות אחרונות (Yedioth Ahronoth / ynet): "מרותק למיטה, תלוי במנות דם

Denmark Denmark: Novo Nordisk faced challenges in 2025 from the American competitor Eli Lilly. 5

Politiken: Novo Nordisk taber 282 milliarder kroner i markedsværdi

Denmark Denmark: Novo Nordisk faced challenges in 2025 due to competition from the American rival Eli Lilly. 4

Politiken: Novo Nordisk i blodbad på børsen

United States United States: The Trump administration recently negotiated a deal with Eli Lilly and Novo Nordisk to provide their weight loss drugs to Medicare at a discounted rate. 6

CNN: Medicare opens door to covering blockbuster drugs for weight loss